The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127405151 12740515 1 I 20120320 20160902 20160913 20160913 EXP ES-BAXTER-2016BAX046085 BAXTER 71.03 YR Y 0.00000 20160913 MD ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127405151 12740515 1 PS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown U 12142 1425 MG POWDER FOR SOLUTION FOR INJECTION
127405151 12740515 2 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown U 12142 1425 MG POWDER FOR SOLUTION FOR INJECTION
127405151 12740515 3 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown U 12142 1425 MG POWDER FOR SOLUTION FOR INJECTION
127405151 12740515 4 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown U 12142 1425 MG POWDER FOR SOLUTION FOR INJECTION
127405151 12740515 5 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown U 12142 1425 MG POWDER FOR SOLUTION FOR INJECTION
127405151 12740515 6 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown U 12142 1425 MG POWDER FOR SOLUTION FOR INJECTION
127405151 12740515 7 SS RITUXIMAB RITUXIMAB 1 Unknown U 0 715 MG
127405151 12740515 8 SS RITUXIMAB RITUXIMAB 1 Unknown U 0 940 MG
127405151 12740515 9 SS RITUXIMAB RITUXIMAB 1 Unknown U 0 940 MG
127405151 12740515 10 SS RITUXIMAB RITUXIMAB 1 Unknown U 0 940 MG
127405151 12740515 11 SS RITUXIMAB RITUXIMAB 1 Unknown U 0 940 MG
127405151 12740515 12 SS RITUXIMAB RITUXIMAB 1 Unknown U 0 940 MG
127405151 12740515 13 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown U 0 144 MG
127405151 12740515 14 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown U 0 144 MG
127405151 12740515 15 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown U 0 144 MG
127405151 12740515 16 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown U 0 144 MG
127405151 12740515 17 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown U 0 144 MG
127405151 12740515 18 SS FLUDARABINE FLUDARABINE PHOSPHATE 1 Unknown U 0 144 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127405151 12740515 1 Chronic lymphocytic leukaemia
127405151 12740515 7 Chronic lymphocytic leukaemia
127405151 12740515 13 Chronic lymphocytic leukaemia

Outcome of event

Event ID CASEID OUTC COD
127405151 12740515 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127405151 12740515 Constipation
127405151 12740515 Gastritis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127405151 12740515 1 20111114 20111116 0
127405151 12740515 2 20111212 20111215 0
127405151 12740515 3 20120109 20120112 0
127405151 12740515 4 20120206 20120209 0
127405151 12740515 5 20120305 20120308 0
127405151 12740515 6 20120403 20120405 0
127405151 12740515 7 20111114 20111116 0
127405151 12740515 8 20111212 20111215 0
127405151 12740515 9 20120109 20120112 0
127405151 12740515 10 20120206 20120209 0
127405151 12740515 11 20120305 20120308 0
127405151 12740515 12 20120403 20120405 0
127405151 12740515 13 20111114 20111116 0
127405151 12740515 14 20111212 20111215 0
127405151 12740515 15 20120109 20120112 0
127405151 12740515 16 20120206 20120209 0
127405151 12740515 17 20120305 20120308 0
127405151 12740515 18 20120403 20120405 0